Korea Investment Corp Pfizer Inc Transaction History

Korea Investment Corp

$38.6 Billion
Q1 2024

A detailed history of Korea Investment Corp transactions in Pfizer Inc stock. As of the latest transaction made, Korea Investment Corp holds 3,632,852 shares of PFE stock, worth $102 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

3,632,852

Previous 3,974,650 8.6%

Holding current value

$102 Million

Previous $114 Million 11.9%

% of portfolio

0.26%

Previous 0.31%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $8.85 Million - $10.2 Million	-341,798 Reduced 8.6%	3,632,852 $101 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $17.4 Million - $22.7 Million	667,547 Added 20.19%	3,974,650 $114 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $34.2 Million - $40 Million	-1,065,852 Reduced 24.37%	3,307,103 $110 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $14.2 Million - $16.4 Million	-392,289 Reduced 8.23%	4,372,955 $160 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $22.7 Million - $29.6 Million	-577,120 Reduced 10.8%	4,765,244 $194 Million

Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $15.1 Million - $19.7 Million	361,034 Added 7.25%	5,342,364 $274 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $3.44 Million - $4.2 Million	78,601 Added 1.6%	4,981,330 $218 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $19.6 Million - $23.2 Million	421,036 Added 9.39%	4,902,729 $257 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $3.18 Million - $3.93 Million	-69,411 Reduced 1.53%	4,481,693 $232 Million
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $62.7 Million - $93 Million	1,518,117 Added 50.05%	4,551,104 $269 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $4.69 Million - $6.03 Million	119,523 Added 4.1%	3,032,987 $130 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $2.23 Million - $2.53 Million	-62,155 Reduced 2.09%	2,913,464 $114 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $15.8 Million - $17.8 Million	470,694 Added 18.79%	2,975,619 $108 Million
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $9.12 Million - $11.6 Million	272,529 Added 12.21%	2,504,925 $92.2 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $28.6 Million - $33.6 Million	-901,800 Reduced 28.77%	2,232,396 $81.9 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $41.4 Million - $50.3 Million	-1,375,300 Reduced 30.5%	3,134,196 $102 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $6.1 Million - $8.71 Million	-225,500 Reduced 4.76%	4,509,496 $147 Million
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $12 Million - $13.6 Million	365,100 Added 8.35%	4,734,996 $186 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $464,607 - $602,459	14,300 Added 0.33%	4,369,896 $157 Million
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $1.72 Million - $1.93 Million	-46,400 Reduced 1.05%	4,355,596 $189 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $5.51 Million - $6.06 Million	147,037 Added 3.46%	4,401,996 $187 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $3.02 Million - $3.44 Million	-78,400 Reduced 1.81%	4,254,959 $186 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $12.9 Million - $15.7 Million	-375,560 Reduced 7.98%	4,333,359 $191 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $2.97 Million - $3.17 Million	90,200 Added 1.95%	4,708,919 $0
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $1.25 Million - $1.45 Million	-39,085 Reduced 0.84%	4,618,719 $164 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $18.4 Million - $19.5 Million	552,200 Added 13.45%	4,657,804 $169 Million
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $127 Million - $140 Million	4,105,604	4,105,604 $147 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Account

Korea Investment Corp Pfizer Inc Transaction History